Rot1 is an essential yeast protein originally shown to be implicated in such diverse processes such as β-1,6-glucan synthesis, actin cytoskeleton dynamics or lysis of autophagic bodies. More recently also a role as a molecular chaperone has been discovered. Here, we report that Rot1 interacts in a synthetic manner with Ost3, one of the nine subunits of the oligosaccharyltransferase (OST) complex, the key enzyme of N-glycosylation. The deletion of OST3 in the rot1-1 mutant causes a temperature sensitive phenotype as well as sensitivity toward compounds interfering with cell wall biogenesis such as Calcofluor White, caffeine, Congo Red and hygromycin B, whereas the deletion of OST6, a functional homolog of OST3, has no effect. OST activity in vitro determined in membranes from rot1-1ost3Δ cells was found to be decreased to 45% compared with wild-type membranes, and model glycoproteins of N-glycosylation, like carboxypeptidase Y, Gas1 or dipeptidyl aminopeptidase B, displayed an underglycosylation pattern. By affinity chromatography, a physical interaction between Rot1 and Ost3 was demonstrated. Moreover, Rot1 was found to be involved also in the O-mannosylation process, as the glycosylation of distinct glycoproteins of this type were affected as well. Altogether, the data extend the role of Rot1 as a chaperone required to ensure proper glycosylation.
Introduction
Protein glycosylation of eukaryotic secretory and membranebound proteins, either in the form of the N-glycosylation of asparagine residues or the O-glycosylation of serine/threonine residues, is a fundamental and the most abundant protein modification in lower and higher eukaryotes, serving many intra-and extracellular functions (Spiro 2002; Helenius and Aebi 2004; Lehle et al. 2006; Ohtsubo and Marth 2006) .
The pivotal step of the N-glycosylation pathway is the en bloc transfer of the high-mannose core oligosaccharide Glc 3 Man 9 GlcNAc 2 from the lipid carrier dolicholphosphate (Dol-P) to the selected Asn-X-Ser/Thr sequences of the nascent polypeptide chain in the lumen of the endoplasmic reticulum (ER). The enzyme that catalyzes this process is a multisubunit membrane complex, called oligosaccharyltransferase (OST; Knauer and Lehle 1999; Dempski and Imperiali 2002; Yan and Lennarz 2005b; Kelleher and Gilmore 2006; Schwarz and Aebi 2011) . Purification of OST from yeast and genetic methods identified nine proteins as constituents of the complex. Five of them, Wbp1, Swp1, Stt3, Ost1 and Ost2, are essential for the viability of the cell, whereas Ost3, Ost4, Ost5 and Ost6 are not essential, but are required for maximal OST activity. Apart from Stt3, identified as the catalytic subunit (Igura et al. 2008; Nasab et al. 2008; Hese et al. 2009; Lizak et al. 2011) , the specific function of the various other components is largely enigmatic. For the homologous Ost3 and Ost6 proteins, it was shown that they are alternatively present in the OST together with the other subunits forming two distinct complexes (Schwarz et al. 2005; Spirig et al. 2005 ) differing in their substrate-specific activities at the level of individual glycosylation sites ). In addition, Ost3 and Ost6 exhibit oxidoreductase activity and bind specific polypeptides, both non-covalently and via transient disulfide bonds. These subunits are thought to slowdown early stages in protein folding, maintaining the nascent polypeptide chain in a glycosylation competent conformation ). There is also evidence that Ost3/Ost6 may specify the interaction with different translocation complexes (Yan and Lennarz 2005a) .
O-Glycosylation in yeast is restricted exclusively to the O-mannosylation of serine/threonine residues forming short linear oligomannose chains consisting of up to four mannose residues. O-Mannosylation, first identified in yeast (Babczinski and Tanner 1973) , was assumed for a long time to occur exclusively in fungi. However, it is now clear that this type of O-glycosylation is conserved throughout the animal kingdom, including human (Lehle et al. 2006; Lommel and Strahl 2009) . Similarly as for N-glycosylation, but differently from the other types of O-glycosylation, O-mannosylation is initiated in the ER, while the nascent polypeptide is entering the lumen. The initial mannosyltransfer reaction is catalyzed by distinct complexes of the Dol-P-Man:protein O-mannosyltransferase (PMT) family, originally discovered in yeast (Strahl-Bolsinger et al. 1993; Gentzsch and Tanner 1996) . It has also been shown that the N-and O-glycosylation machineries may compete for the protein substrate (Harty et al. 2001; Ecker et al. 2003) .
ROT1, encoding an essential ER-localized membrane protein, was initially reported as a gene required for β-1,6-glucan synthesis (Bickle et al. 1998; Machi et al. 2004 ). Mutations of ROT1 cause pleiotropic defects in cell wall synthesis, cytoskeleton dynamics or lysis of autophagic bodies (Takeuchi, Kimata, Hirata et al. 2006; ). More recently, it was demonstrated that Rot1 can function as a general chaperone exhibiting anti-aggregation activity in vitro, and in vivo the rot1-2 mutation caused an accelerated degradation of several proteins of the secretory pathway via ER-associated degradation (Takeuchi et al. 2008 ). Furthermore, ROT1 was shown to interact genetically with KAR2, encoding the yeast BiP, suggesting a cooperation of these two protein in the folding of nascent proteins (Takeuchi, Kimata, Hirata et al. 2006) .
We previously observed that the overexpression of ROT1 in sec59-1 cells, impaired in dolichol kinase, suppresses the temperature-sensitive phenotype of this mutant (Orlowski et al. 2007 ). As Dol-P is a key component in the formation of lipid-linked oligosaccharide, we asked whether a direct role of Rot1 in protein glycosylation can be demonstrated. Here, we show that N-glycosylation is impaired in vivo and in vitro in rot1-1ost3Δ cells and that Rot1 physically interacts with the Ost3 subunit of OST. Quite unexpected, we observe that Rot1 is also required for the O-mannosylation of proteins.
Results

Synthetic interaction of ROT1 and OST3
OST3 and OST6 are two closely related, not essential subunits of two distinct OST isoforms, required for efficient N-glycosylation (Knauer and Lehle 1999; . As shown in Figure 1 , the deletion of OST6 displayed a growth phenotype, when stressed by agents known to interfere with cell wall biogenesis, such as Calcofluor White, caffeine, Congo Red or hygromycin B, while the ost3Δ strain proved more or less resistant at the concentrations used, similar to wild type. The deletion of ROT1 is known to be lethal, but the rot1-1 mutant is viable and was hardly affected by aforementioned agents. However, the growth of a rot1-1ost3Δ double mutant was abolished, while the rot1-1ost6Δ strain was not affected in a synthetic manner by these drugs and displayed only the phenotype of the ost6Δ single mutant. Similarly, only rot1-1ost3Δ cells reveal a temperature-sensitive growth phenotype. Altogether, the data suggest a synthetic interaction between Rot1 and Ost3 that does not apply to Rot1 in combination with Ost6.
Rot1 is required for N-glycosylation
The synthetic interaction between ROT1 and OST3 pointed to an involvement of ROT1 in N-glycosylation. To investigate this in more detail, we examined the glycosylation status of several well-characterized soluble and membrane-bound glycoproteins in single-and double-mutant strains. As depicted in Figure 2 , western blot analysis showed an underglycosylation of the soluble, vacuolar carboxypeptidase Y (CPY) only in rot1-1ost3Δ cells, indicated by the appearance of glycoforms migrating faster than mature CPY, lacking one, two or three N-glycan chains. CPY containing four chains is the dominant species in wild-type cells. Similarly, also the vacuolar membrane glycoprotein dipeptidyl aminopeptidase B (DPAP B), the plasma membrane cell wall integrity sensor Mid2, or Gas1, a GPI-anchored β-1,3-glucanosyltransferase, involved in cell wall remodeling displayed an underglycosylation pattern only in rot1-1ost3Δ, but not in rot1-1ost6Δ and single-deletion strains, respectively. The last two proteins carry also O-glycans. However, as it will be shown later (Figure 4) , the underglycosylation is due exclusively to the loss of N-linked glycans.
Altered OST and cis-prenyltransferase activity in the rot1-1ost3Δ mutant The phenotype of underglycosylation of proteins could be caused, among others, by a reduced activity of OST, or might be due to a reduced amount of the Dol-P precursor oligosaccharide. We therefore determined OST activity in vitro in microsomal membranes isolated from these strains. As shown in Figure 3A , OST activity reflected the underglycosylation observed in vivo. Whereas membranes from ost3Δ and ost6Δ single mutants displayed only a small decrease in activity, in the double-mutant rot1-1ost3Δ, but not in rot1-1ost6Δ, it was severely reduced, indicative for the specific synthetic interaction between Rot1 and Ost3. We also determined the Fig. 1 . Synthetic genetic interaction of ROT1 and OST3. Analysis of cell growth in dependency of drugs and temperature. About 3 µL of a serial 1:10 dilution of the indicated strains grown in a liquid medium were plated on YEPD plates containing no additions, 5 µg/mL Calcofluor White, 5 mM caffeine, and 15 µg/mL Congo Red or 20 µg/mL hygromycin B starting with 3 × 10 4 cells (left). Plates were incubated for 72 h at 25°C in the case of drug treatment or at 37°C for the analysis of temperature sensitivity. activity of cis-prenyltransferase, the first enzyme committed to the biosynthesis of the dolichol backbone, encoded by RER2 localized to the ER (Grabinska and Palamarczyk 2002) . As can be seen in Figure 3B , also this activity was significantly reduced in a synthetic manner in rot1-1ost3Δ cells, indicating that disturbed Rot1 function in combination with impaired glycosylation due to the deletion of OST3 may affect earlier steps of this pathway as well (for further discussion see below).
Rot1 affects O-mannosylation in vivo and in vitro
The fact that there is a link between N-and O-glycosylation (Ecker et al. 2003) and both processes in yeast occur while the nascent, unfolded polypeptide is translocated into the ER lumen, prompted us to ask whether Rot1 may also take an active role in O-mannosylation. As mentioned above, the initial mannosyltransfer reaction is catalyzed by heteromeric and homomeric, respectively, complexes of the Pmt1/Pmt2 and the Pmt4 subfamilies. The complexes differ in their target protein substrate specificity Tanner 1996, 1997; Ecker et al. 2003; Lommel and Strahl 2009) . As shown in Figure 4 , the western blot analysis of endochitinase Cts1, an exclusively O-mannosylated protein, revealed that it migrated faster in rot1-1ost3Δ, reflecting a defect in O-mannosyltransfer. Such a reduced O-mannosyltransferase activity could also be demonstrated in vitro in microsomal membranes ( Figure 5 ). Pmt activity in rot1-1ost3Δ was decreased to 45% compared with wild-type, rot1-1 or ost3Δ single-mutant strains.
Besides Cts1, further O-mannosylated proteins were investigated, like Ccw5, Gas1 and Mid2. In the case of Gas1 and Mid2, also N-glycosylation of the protein occurs (see above).
In order to exclusively monitor O-mannosylation of these proteins, in the case of Gas1, samples were treated with endoglycosidase H (Endo H) to remove N-glycan chains, while for Mid2, a mutant variant (Mid2-N35A) was analyzed, in which the single N-glycan chain at asparagine residue 35 was deleted by substitution of asparagine to alanine. As can be seen in Figure 4 , the O-mannosylation of these proteins, in contrast to chitinase Cts1, was not altered in rot1-1ost3Δ cells. The faster mobility of Gas1 in Figure 4 (compare lanes 1 and 3) was due to a defect in N-glycosylation and hence could not be observed upon treatment with Endo H (lanes 4 and 6). Similarly, the mobility shift of Mid2-hemagglutinin (HA) in rot1-1ost3Δ (lanes 7 and 8) was not the result of defective O-mannosylation, but rather was due to the lack of N-glycosylation, as the Mid2-(N35A)-HA mutant variant, lacking the N-glycosylation site, had the same mobility in wild-type and rot1-1ost3Δ cells (lanes 2 and 6).
So far, only Cts1 showed an impairment of O-mannosylation. Since chitinase is exclusively mannosylated by the Pmt1-Pmt2 complex in contrast to Gas1, which is a substrate for the Pmt4 complex, and Ccw5 as well as Mid2, which are mannosylated by both Pmt1-Pmt2 and Pmt4, we reasoned that only proteins modified by the Pmt1-Pmt2 (mCPY) and of the underglycosylated forms, lacking 1-3 oligosaccharide chains, are indicated. Samples of 100-µg protein were loaded for DPAP B and Gas1 and were detected with anti-Gas1 or anti-DPAP B antisera. Twenty micrograms was applied for Mid2-HA glycosylation analysis; membranes were probed with the anti-HA antibody. One hundred and fifty micrograms of protein was analyzed for CPY with the anti-CPY antiserum. Rot1 and protein glycosylation complex were affected. Thus, a further target protein of this type, Kre9, was analyzed. However, for unknown reason, this protein was not detectable in the rot1-1ost3Δ double mutant (Figure 4 , lane 5), compared with wild-type or single mutant strains. It is assumed that Kre9 is degraded in this genetic background, because of defective O-mannosylation. A similar observation, i.e. lack of detection, was also made when investigating Kre5 in rot1-2, which is another mutant allele of ROT1 (Takeuchi et al. 2008) .
Physical interaction between Rot1 and Ost3
Previous experiments showed that Rot1 and Ost3 interact at the genetic level in a synthetic manner. In order to demonstrate also a physical interaction between these two proteins, a strain was constructed co-expressing OST3-ZZ-and ROT1-HA-tagged variants to perform co-immunoprecipitation experiments. A detergent-solubilized extract from microsomal membranes was isolated and applied to either magnetic beads coupled with the anti-HA antibody recognizing the HA epitope or an IgG-Sepharose affinity matrix recognizing the protein A (ZZ) epitope. After washing to remove non-interacting proteins, the eluate fraction was analyzed for Ost3 (upper panel) and Rot1 (lower panel). As shown in Figure 6 , both proteins co-fractionated (lanes 5 and 6) with either the anti-HA matrix or the IgG matrix as bait for pulling down the HA and ZZ epitope, respectively. It should be mentioned that Rot1 is prone to aggregation and gives rise to doublet bands (lanes 5 and 6, indicated by asterisks). In control extracts from membranes, expressing only Rot1-HA but no Ost3-ZZ (lane 7), or expressing an unrelated membrane protein, Dpm1-HA (lane 8), no binding to IgG-Sepharose was detectable. In a further control using Sepharose (lane 9) instead of IgG-Sepharose as an affinity matrix, also no interaction was observed. This rules out that Rot1 and Ost3 bind in a non-specific manner.
Discussion
In this study, we extend the multifunctional role of Rot1 by demonstrating that it is needed to ensure both proper protein Nand O-glycosylation. Rot1 is an essential ER protein that originally has been related to cell wall biosynthesis, actin cytoskeleton dynamics (Bickle et al. 1998; Machi et al. 2004; Juanes et al. 2007 ) and more recently shown to function in protein folding as a molecular chaperone (Takeuchi, Kimata, Hirata et al. 2006; Takeuchi et al. 2008 ). Rot1 does not have any known functional motif and the details of its molecular function have not been elucidated. Rot1 was shown to be transported to the ER by an signal recognition particle (SRP)-independent post-translational mechanism involving Sec61/Sec63 and is anchored to the ER membrane by a transmembrane domain at its C-terminal region (Juanes et al. 2008 (Juanes et al. , 2010 .
In the first instance, a phenotypic analysis of the ROT1 mutant allele rot1-1 in combination with the deletion of OST3, encoding a non-essential subunit of OST, revealed a specific genetic interaction that causes temperature-dependent synthetic 4) and eluate fractions (lanes 5-9) were analyzed by western blot with anti-IgG (for Ost3-ZZ) and anti-HA (for Rot1-HA) antibodies, respectively. As further controls, to rule out that Rot1-HA binds non-specifically to IgG-Sepharose, extracts expressing only Rot1-HA (lane 7) or Dpm1-HA (lane 8), but no Ost3-ZZ, were analyzed. Rot1 is subject to aggregation and prone to form doublet bands, as indicated by asterisks.
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lethality and increased sensitivity of cells when stressed by drugs interfering with cell wall biogenesis (Figure 1 ). These deficiencies were not observed by the deletion of its paralog OST6. An involvement in N-glycosylation was then further substantiated by demonstrating that in rot1-1ost3Δ cells both soluble and membrane-bound model N-glycoproteins were underglycosylated in vivo, and in accord with this finding, we measured a reduced OST activity in vitro. Finally, by co-immunoprecipitation experiments, a physical interaction between Rot1 and Ost3 could be verified.
OST is a multifunctional enzyme that acts at a pivotal step of the secretory pathway, at which protein translation and translocation into the ER, biosynthesis of lipid-linked glycosyl donor substrates, as well as protein glycosylation and protein folding converge. In view of the proposed role of Rot1 as a molecular chaperone of the ER, it is not quite unexpected that it is also required during the glycosylation of the nascent and yet unfolded protein by assisting or modulating the OST complex. Thus, it is conceivable that Rot1 could contribute to the assembly of an optimal complex or to a better positioning of OST to the polypeptide or translocation site. Alternatively, it could help keeping the polypeptide in a glycosylation competent state under certain conditions. It has been reported that the rot1-2 mutant allele causes the activation of the UPR pathway, and ROT1 genetically interacts with KAR2 (BIP) in an allele-specific manner, suggesting cooperation in protein folding (Takeuchi, Kimata, Hirata et al. 2006; Takeuchi et al. 2008 ). Kar2/BiP in yeast has been shown to be involved in various steps of protein maturation in the ER. It functions in protein translocation into the ER (Corsi and Schekman 1997) , but also at later stages facilitating folding (Simons et al. 1995) and even contributes to ER-associated degradation (Fewell et al. 2001) . Worth mentioning in this context is the finding of a genetic interaction between kar2 and wbp1 mutations, the letter being an essential component of OST. Interestingly, OST activity in kar2wbp1 and wbp1 strains was the same (te Heesen and Aebi 1994) in contrast to the results obtained here with the rot1-1ost3Δ mutant.
Why Ost3, but not its homolog Ost6, causes a synthetic interaction with rot1-1 is not clear at the moment. The identity between both proteins with 21% is rather low, but they display a similar membrane topology containing four transmembrane spanning domains and an ER luminal thioredoxin-like domain at the N-terminal region, for which a crystal structure exists ). Apart from that, no primary structural differences or motifs can be assigned to Ost3/Ost6 that would allow predicting sites for interaction with Rot1. Ost3 and Ost6 are accessory subunits of two isoforms of the OST complex and contribute to the specificity and efficiency at the level of individual glycosylation sites (Schwarz et al. 2005; Spirig et al. 2005) . Ost3/Ost6 function by transiently binding stretches of the nascent substrate to inhibit protein folding and thus increasing glycosylation efficiency of nearby Asn residues Jamaluddin et al. 2011) . Polypeptide binding to Ost3/Ost6 is thought to be transient and by mixed disulfide bonds. This is mediated by their ER luminal thioredoxin-like domain causing a structural change in the oxidized form and thus forming a groove complementary to the characteristic of the acceptor peptide stretch. Eukaryotic OST requires flexible domains of an unfolded protein substrate, when compared with single protein OST from bacteria, which can also act on folded proteins (Kowarik et al. 2006) . From an evolutionary point of view, Ost3/Ost6 are the most recently added subunits of OST (Kelleher and Gilmore 2006) and the physically most peripheral ones (Kelleher et al. 2003) . They are also thought to couple OST to the translocation machinery to associate with different translocons (Yan and Lennarz 2005a) . But this has been challenged, by recent findings that Ost3 and Ost6 had essentially complementary functions .
We also observed a decrease in cis-prenyltransferase activity in rot1-1ost3Δ cells, a key enzyme in early steps of the glycosylation pathway, encoded by RER2. It provides dolichol needed for the formation of glycosyl donor substrates. This deficiency, however, may be different from the effect of Rot1 on OST activity. We hypothesize that this could be the result of an indirect effect of loss of Rot1 function by downregulating glycosyl donor formation due to defective glycosylation and/or due to poorly folding. Whether the amount of the Dol-P precursor is indeed reduced has not been demonstrated in this study, but it has been reported that the overexpression of RER2 in sec59-1, having a defect in dolichol kinase, is able to improve glycosylation (Orlowski et al. 2007 ). Hence, the activity of Rer2 is indeed able to affect the glycosylation process. Alternatively, Rot1 or Rot1/Ost3 could also play a direct, presumably protective function for Rer2. Interestingly, in a genome-wide transcriptional profiling in Candia albicans, the transcript level of CaROT1 increased by shutting of CaRER2 (Juchimiuk et al. in preparation) . Finally, also an indirect influence by the lack of O-mannosylation cannot be ruled out for the decrease in Rer2 activity as Dol-P plays also a role in this process as a glycosyl donor substrate.
Our study further revealed for the first time an involvement of Rot1 in O-mannosylation at least for some O-glycoproteins. Protein O-mannosylation in yeast is initiated in the ER by the transfer of mannose from Man-P-Dol to serine and threonine residues during the translocation of the secretory protein into the ER (Ruiz-Herrera and Sentandreu 1975), albeit it is possible in some cases that O-mannosylation can occur after the protein has entered the ER (Harty et al. 2001) . Considering the role of Rot1 as a general chaperone and the fact that N-and O-glycosylation can compete for the same protein and therefore must be tightly coordinated, it is not too astonishing that Rot1 is also engaged in O-mannosylation, while the target protein is still in its unfolded state. A loss of Rot1 may then cause hypo-mannosylation under specific conditions and situations. Evidence has been presented that O-mannosylation might play a general role in the solubilization of proteins in the ER and defective O-mannosylation can result in the induction of unfolded protein response (Travers et al. 2000; Nakatsukasa et al. 2004; Murakami-Sekimata et al. 2009; Arroyo et al. 2011 ) similar to defects in N-glycosylation.
Among the several O-glycoproteins tested, so far only Cts1 could be identified to be subject to Rot1 deficiency as well as Kre9, which, however, was not detectable in the rot1-1ost3Δ background compared with wild-type and single mutants, presumably due to degradation as a result of defective O-mannosylation. Why the other O-mannoproteins analyzed were not affected, can be only a matter of speculation. As mentioned above, O-mannosylation is catalyzed by the evolutionarily conserved PMT family classified into PMT1 (comprising Pmt1/5 isoforms), PMT2 (comprising Pmt2/3/6 isoforms) and PMT4 (Pmt4) subfamilies. They form distinct heteromeric (Pmt1-Pmt2) and homomeric (Pmt4-Pmt4) complexes, which in yeast are responsible for the vast majority of mannosyltransferase activity. They exhibit different target site specificities (Hutzler et al. 2007; Lommel and Strahl 2009) , the signatures of which are largely elusive and remain to be determined. Merely for Pmt4, PMT membrane association was found to be a determinant for substrate recognition (Hutzler et al. 2007 ). Cts1, a soluble and secreted glycoprotein, is known to be a substrate exclusively for Pmt1-Pmt2, whereas Gas1 is a target for Pmt4-Pmt4, or in the case of Mid2 and Ccw5, both complexes contribute to glycosylation. Furthermore, it is conceivable that due to a compensatory cooperation, other PMT complexes may contribute to ensure O-mannosylation. Thus, it was reported earlier that under certain physiological conditions, Pmt1 can also interact with Pmt3 and Pmt5 with Pmt2 (Girrbach and Strahl 2003) . Finally, as Gas1, Mid2 and Ccw5 are membrane bound and anchoring increases residence time in the ER, Pmt4-Pmt4-mediated O-mannosylation may have a different kinetics of the mannosyltransfer and is more efficient, perhaps in addition in a posttranslational manner. In this context, it is worth mentioning that several mutant secretory proteins that are unable to fold properly are O-mannosylated by Pmt1 and/or Pmt2, whereas their wild-type counterparts are not (Coughlan et al. 2004 ).
Rot1 homologs have been identified so far only in fungi. However, proteins with similar function may also occur in the ER of higher eukaryotes, because of the evolutionary conservation of the N-and O-glycosylation as well as of the protein folding pathway. A genome-wide screening for Rot1 substrates and further investigation of the role of Rot1 in the mentioned processes will eventually lead to a better understanding of this multifunctional protein.
Material and methods
Strains, plasmids and media Yeast strains used are listed in Table I . Strains were grown in YEPD medium (1% yeast extract, 2% bacto-peptone, 2% glucose) or in selective YNBD medium (0.67% yeast nitrogen base, 0.5% casamino acids, 2% glucose) supplemented with amino acids and nucleotide bases, as required.
To construct the expression plasmids pVT100-(TRP1)-Rot1-ZZ and pVT100-(URA3)-Rot1-HA, genomic ROT1 was amplified from W303-1A by polymerase chain reaction (PCR) and engineered for cloning purpose with HindIII and BamHI restriction sites at the 5′-and 3′-ends, respectively, and ligated into the HindIII/BamHI cut vectors pVT100-(TRP1)-ZZ and pVT100-(URA3)-HA, respectively, placing ROT1 under the control of the constitutive ADH1 promoter. The constructs were sequenced and the functional expression of Rot1 containing the ZZ epitope or the HA epitope in frame at the C terminus were verified by immunoblotting and complementation of the ts growth phenotype of the rot1-1rot2-1 mutant. For the PCR amplification of ROT1, the following primers were used: ROT1 fw (5′-AGCGGCCGCATGAATTGGCTGTTTTTGGTCTCGC-3′) and ROT1 rev (5′-AGCGGCCGCTTATTTGAATGGT GCCGATAACCTT AGTAAAGC-3′).
Chromosomal deletions of OST3 and OST6 were performed using gene-specific PCR primers and the pFA6a-natMX6 cassette as a template (Goldstein and McCusker 1999) . PCR products were transformed into rot1-1. Homologous integration resulted in the deletion of nucleotides 60-992 from the 1053-nucleotide open reading frame (ORF) of OST3 and the deletion of nucleotides 60-935 from the 999-nucleotide ORF of OST6. Successful deletions of genes were confirmed by PCR using 11genomic DNAs obtained from nourseothricinresistant transformants. Deletion primers will be provided on request.
For monitoring the glycosylation status, the following plasmids expressing C-terminal HA-tagged versions of the respective genes were used: pVT100-Kre9-HA, YEp352-Mid2-HA, YEp352-Mid2-HA(N35A) and YEp352-Ccw5-HA. Transformation into yeast was carried out using the standard techniques.
Phenotype analysis of rot1Δ cells Analysis of drug or temperature sensitivity of different strains was performed on YEPD plates in the presence of the various drugs at 25°C or for temperature sensitivity at 37°C, respectively, as specified. About 3 µL of serial 10-fold dilutions from a liquid culture of the mid-logarithmic phase were spotted on agar plates, starting at 3 × 10 4 cells and incubated for 72 h.
Biochemical methods Enzyme assays. Membrane isolation and determination of OST activity was performed as described (Sharma et al. 1981; Zufferey et al. 1995) . OST activity was determined according to Sharma et al. (1981) . The determination of PMT activity was carried out according to Strahl-Bolsinger and Tanner (1991) . Cis-prenyltransferase activity was tested as published in Szkopinska et al. (1997) .
Immunoaffinity chromatography
To verify physical interaction between Rot1 and Ost3, yeast membranes were collected by centrifugation, and the membrane pellet was resuspended in 30 mM Tris-HCl, pH 7.5, 3 mM MgCl 2 , 1 mM dithiothreitol (DTT), 3% glycerol and adjusted to 100 μL of final volume containing 1% 
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Rot1 and protein glycosylation octylglucoside (OG), 0.5 M KCl, 20 mM Tris-Cl, pH 7.4, and 1 mg of membrane protein. After incubation on ice for 25 min, the mixture was centrifuged for 40 min at 120,000 × g, and the supernatant was applied for immunoprecipitation. Two different affinity media were used. (i) IgG-Sepharose 6 (GE Healthcare) was equilibrated with 15 mM Tris-HCl, pH 7.5, 1.5 mM MgCl 2 , 150 mM NaCl and 17.5% glycerol and incubated with solubilized membrane extract for 1 h at 4°C with gentle shaking. Sepharose beads were centrifuged and washed five times to remove unbound material with 2 vol. of buffer containing 1.5 mM Tris-HCl, pH 7.5, 150 mM NaCl, 15 mM MgCl 2 , 0.1% OG and 17.5% glycerol. Elution was carried out with 100 mM glycine-HCl buffer, pH 3.3, and fractions of 0.4 mL were collected and analyzed by western blot using antibodies against the ZZ or HA epitopes. (ii) As a further affinity material, Dynabeads-Protein A (Invitrogen) coupled with the anti-HA antibody was applied. Binding and elution was performed following the manufacturer's instructions. Dynabeads-Protein A was coupled with 5 μg of anti-HA antibody in 200 μL of antibody-binding buffer and incubated under rotation for 10 min at room temperature. After washing four times with washing buffer, beads were incubated with membrane extract for 20 min at room temperature followed again by washing four times with washing buffer. Dissociation of the complex was carried out by adding 20 μL of elution buffer and analyzed by western blotting using antibodies against the ZZ or HA epitopes.
Western blot analysis. Following sodium dodecyl sulfatepolyacrylamide gel electrophoresis, proteins were blotted to nitrocellulose, blocked with 5% non-fat milk and decorated with specific antibodies. CPY was analyzed from a total cell lysate obtained by breakage with glass beads and the removal of membranes by centrifugation at 48,000 × g. The membrane fraction was used for immunodetection of Mid2-HA, Mid2-(N32A)-HA and DPAP B. Chitinase isolated from cell walls was detected according to Kuranda and Robbins (1991) and Immervoll et al. (1995) . The analysis of Ccw5, released from cell walls by 30 mM NaOH overnight at 4°C, was carried out according to Mrsa et al. (1997) .
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